FDA Defends Its Oversight of Generic Drug Quality

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb and CDER director Janet Woodcock rallied Friday against recent media claims that generics are of lesser quality than brand name drugs, outlining methods the agency takes to protect their quality and effectiveness.

To View This Article:

Login

Subscribe To Drug Industry Daily